Literature DB >> 22024369

Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists.

Carlota Quintal1, Patrícia Mendes.   

Abstract

OBJECTIVES: The objectives of this study were to identify: perceptions regarding underuse and characteristics of generic medicines; patients' attitudes towards drug substitution and pharmacists' attitudes towards substitution recommendation.
METHODS: Two questionnaires were designed and interviewer-administered - one to patients and another to pharmacists. A binary variable 'correct understanding' was created and multiple logistic regression analysis was used to identify factors associated with experience and willingness to accept generic medicine substitution. Statistical analyses were performed by SPSS version 19.0.
RESULTS: All of the 417 patients knew the term 'generic medicine'. Level of education, experience and discussion with doctor were significantly associated with correct understanding. 77.5% of respondents had consumed generic medicines and 88.7% (64.5%) were willing to accept drug substitution based on doctor's (pharmacist's) recommendation. Having at least one chronic condition, discussion with doctor and perception that generic drug substitution is cost-saving were significantly associated with experience. In addition to the last two, having correct understanding and having experience were significantly associated with willingness to accept generic drug substitution. 91.6% of pharmacists (95 respondents) said that drug substitution is recommended in their pharmacies.
CONCLUSIONS: More information should be given to patients preferably by doctors and pharmacists. Prescription should be encouraged and experience promoted.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024369     DOI: 10.1016/j.healthpol.2011.10.001

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  25 in total

1.  Introduction of therapeutic reference pricing in Slovenia and its economic consequences.

Authors:  Nika Marđetko; Mitja Kos
Journal:  Eur J Health Econ       Date:  2017-05-27

2.  Patient perceptions of generic medicines: a mixed-methods study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  Patient       Date:  2014       Impact factor: 3.883

3.  Impact of generic substitution practice on care of diabetic patients.

Authors:  Olubukola O Oyetunde; Bolajoko A Aina; Fola Tayo
Journal:  Int J Clin Pharm       Date:  2014-04-10

4.  Consumers' perception of generic substitution in Iran.

Authors:  Nazila Yousefi; Gholamhossein Mehralian; Farzad Peiravian; Samaneh NourMohammadi
Journal:  Int J Clin Pharm       Date:  2015-02-20

Review 5.  Demonstrating Value for Biosimilars: A Conceptual Framework.

Authors:  Sotiris Rompas; Thomas Goss; Sally Amanuel; Victoria Coutinho; Zhihong Lai; Paola Antonini; Michael F Murphy
Journal:  Am Health Drug Benefits       Date:  2015-05

6.  Patients' knowledge and attitude towards therapeutic reference pricing system in Slovenia.

Authors:  Nika Marđetko; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2016-08-08

Review 7.  What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers' and Patients' Perceptions of, and Experiences with, Generic Medicines.

Authors:  Suzanne S Dunne
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

8.  Attitude and Purchase Intention to Generic Drugs.

Authors:  Ricardo Arcaro; Cássia Rita Pereira da Veiga; Wesley Vieira da Silva; Claudimar Pereira da Veiga
Journal:  Int J Environ Res Public Health       Date:  2021-04-26       Impact factor: 3.390

9.  Resource allocation and purchasing arrangements to improve accessibility of medicines: Evidence from Iran.

Authors:  Peivand Bastani; Gholamhossein Mehralian; Rasoul Dinarvand
Journal:  J Res Pharm Pract       Date:  2015 Jan-Mar

Review 10.  A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-05       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.